Celltrion launches ADC cancer drug trials in U.S. while planning additional INDs Celltrion accelerates its global drug ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
GlobalData on MSN13d
FDA approves drug application for Lupin’s heart failure therapyThe US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...
At issue as whether Harry came clean to immigration officials about his cocaine, cannabis and psychedelic mushrooms use, as ...
Vanda Pharmaceuticals Inc. recently made a significant move by filing a new drug application for Tradipitant. The application, targeted at addressing motion sickness, was publicized through a social ...
Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a diversified, vertically integrated global healthcare ...
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
GSK (GSK) announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, Labour and ...
3h
Hosted on MSNFDA grants orphan drug status to Arbor Biotechnologies’ PH1The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation (RPDD) to Arbor Biotechnologies' gene editing therapeutic, ABO-101, to treat ...
Hallucinations in LLMs refer to instances where models generate plausible yet incorrect or unrelated information.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results